Categories: CancerHealthcareNews

Protara Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation Conference

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

NEW YORK, Nov. 06, 2024 (GLOBE NEWSWIRE) — Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that management will participate in a fireside chat at the Guggenheim Inaugural Healthcare Innovation Conference on Wednesday, November 13, 2024, at 2:00 pm ET in Boston.

A live webcast of the fireside chat can be accessed by visiting the Events and Presentations section of the Company’s website: https://ir.protaratx.com. The webcast will be archived for a limited time following the presentation.

About Protara Therapeutics, Inc.

Protara is a clinical-stage biotechnology company committed to advancing transformative therapies for people with cancer and rare diseases. Protara’s portfolio includes its lead candidate, TARA-002, an investigational cell-based therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs). The Company is evaluating TARA-002 in an ongoing Phase 2 trial in NMIBC patients with carcinoma in situ (CIS) who are unresponsive or naïve to treatment with Bacillus Calmette-Guérin (BCG), as well as a Phase 2 trial in pediatric patients with LMs. Additionally, Protara is developing IV Choline Chloride, an investigational phospholipid substrate replacement for patients on parenteral support who are otherwise unable to meet their choline needs via oral or enteral routes. For more information, visit www.protaratx.com.

Company Contact:

Justine O’Malley
Protara Therapeutics
Justine.OMalley@protaratx.com
646-817-2836

Staff

Recent Posts

SmartSKN Launches K-OWN: The World’s first AI custom Korean skincare platform powered by robots

BOSTON, March 14, 2025 /PRNewswire/ -- SmartSKN, a leader in K-Beauty technology, announces the launch…

1 hour ago

Nimblemind.ai Raises $2.5M to Unlock AI-Ready Clinical Data for Healthcare Providers

CHICAGO, March 14, 2025 /PRNewswire/ -- Nimblemind.ai, an AI-powered data infrastructure platform designed to help…

1 hour ago

AI-Powered Healthcare: How ADLINK’s Medical Innovations at HIMSS 2025 Are Transforming Patient Care

Celebrating 30 Years of Innovation Excellence with Advanced OEM Solutions for Healthcare Summary: Successful Showcase:…

1 hour ago

CTG Appoints Dan Stoke Vice President of U.S. Healthcare Business

Growth-Oriented Healthcare IT Leader to Build on CTG’s Strong Industry Legacy; Drive Growth, Innovation, and…

4 hours ago

TruBridge Announces Participation in the KeyBanc Capital Markets Healthcare Forum

MOBILE, Ala.--(BUSINESS WIRE)--TruBridge, Inc. (NASDAQ:TBRG), a healthcare solutions company, today announced that management will participate…

4 hours ago

WTWH Healthcare, a WTWH Media Company, Announces 2025 Aspect Awards Winners

CLEVELAND, March 14, 2025 /PRNewswire/ -- WTWH Healthcare, a WTWH Media company, is proud to…

7 hours ago